Investor Presentaiton
ORION
Five business divisions
20
☑
во
20
•
•
Innovative Medicines
Innovative medicines developed or marketed by Orion, and
which have patent or other product protection.
Branded Products
Orion's innovative legacy products and in-licensed products
with a strong brand name and competitive advantage
Generics and Consumer Health
Generic prescription drugs (including biosimilars) and self-
care products
Animal Health
•
Orion's innovative and in-licensed veterinary medicines and
pro health products for animals
Fermion
• Active Pharmaceutical Ingredients (APIs) for Orion and other
pharmaceutical companies
Generics and Consumer Health
EUR 518 million
43%
Animal Health
EUR 104 million
9%
Fermion EUR 74 million
Net sales
6%
EUR 1,190 million
in 2023
22%
Innovative Medicines
20%
EUR 235 million
Branded Products
EUR 261 million
5
Investor Presentation Orion CorporationView entire presentation